TP53 and cancer: In addition, we performed single-nucleotide variant (SNV) analysis in the 36 GCA patients and found that the top ranking mutated cancer driver-genes31–33 (81% mutation rate) was TP53 (Supplementary Fig. 1b), which agrees with previous gene mutation studies in GCA patients21,27,29,34.